Feladilimab Antibody
Feladilimab (GSK3359609) is an agonist anti-ICOS IgG4 monoclonal antibody that activates T cells, induces IFNγ secretion, and upregulates PD-1/L1. It has demonstrated anti-tumor activity in preclinical studies, supporting its investigation in oncology research for both in vitro immune cell assays and in vivo cancer models.
Product Specifications
Product Name Alternative
IFN-γ, GSK 3359609, GSK3359609, GSK-3359609, Feladilimab, PD-1, PD1/PDL1, PD1, PD-L1, PDL1
Target
COX, PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation, Neuroscience
Concentration
8.65 mg/mL
Purity
97.94% (May vary between batches)
Molecular Weight
145.24 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Tryptase Alpha / Beta-1 (TPSAB1) Antibody (FITC)
Tryptase Alpha / Beta-1 (TPSAB1) Antibody (FITC)
Tryptase Alpha / Beta-1 (TPSAB1) Antibody (FITC)
Potassium Voltage-Gated Channel Subfamily E Member 1 (KCNE1) Antibody
Potassium Voltage-Gated Channel Subfamily E Member 1 (KCNE1) Antibody